NCT01888770

Brief Summary

The purpose of this study is to investigate whether exposure to hypertensive disorders of pregnancy and/or a preterm birth results in alterations in the cardiovascular system during infancy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

June 13, 2013

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 28, 2013

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

May 25, 2016

Status Verified

May 1, 2016

Enrollment Period

6.1 years

First QC Date

June 13, 2013

Last Update Submit

May 23, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Systolic Cardiac Function

    Cardiac Function will be assessed by ECHO at birth and 3 months

    Birth and 3 months

Secondary Outcomes (6)

  • Micro-vascular Structure

    Birth and 3 months

  • Pulse wave velocity and pulse-wave analysis

    Birth and 3 months

  • Cardiac Structure

    Birth and 3 months

  • Cardiac diastolic function

    Birth and 3 months

  • Blood pressure

    Birth and 3 months

  • +1 more secondary outcomes

Study Arms (5)

Normotensive Term

Infants born at term (\>37 weeks) to Normotensive pregnancies

Term Preeclampsia

Infants born at term (\>37 weeks gestation) and exposed to a preeclamptic pregnancy

Preterm Normotensive

Infants born to Normotensive pregnancies at \<37 weeks gestation

Preterm Hypertensive

Infants born to hypertensive pregnancies at \<37 weeks completed gestation

Term Pregnancy-induced Hypertension

Infants born at term (\>37 weeks gestation) and exposed to pregnancy-induced hypertension

Eligibility Criteria

AgeUp to 6 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Study population is drawn from infants admitted to or delivered in the OUH NHS Foundation trust to normotensive or hypertensive pregnancies across a range of gestations. The mothers of these infants form a secondary study cohort.

You may qualify if:

  • Available for assessment within the neonatal period,
  • Parent is willing and able to give informed consent for participation in the study,
  • Physical condition is suitable to allow non-invasive vascular testing,
  • Cases: Diagnosed during pregnancy with preeclampsia or gestational hypertension and/or delivered preterm (\<37 weeks gestation)
  • Controls: No history of gestational hypertension or preeclampsia during this pregnancy and delivered at term (\>37 weeks gestation)

You may not qualify if:

  • Parent is unwilling to give consent,
  • Unavailable for assessment of cardiovascular system,
  • Physical condition unsuitable to allow for non-invasive testing of cardiovascular system,
  • Evidence of congenital cardiovascular disease (with the exception of Persistent Patent Ductus Arterious (PDA) and Atrial Septal Defect (ASD)),
  • Cardiorespiratory instability at time of proposed measures,
  • Active infection at time of proposed study measures,
  • Mother of infant is excluded from the study. (Aged \<16 years, unable or unwilling to consent to study or Physical condition post delivery such that it would preclude participation in the study)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardiovascular Clinical Research Facility, Dept of Cardiovascular Medicine, University of Oxford

Oxford, Oxfordshire, OX3 9DU, United Kingdom

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood, serum, plasma

MeSH Terms

Conditions

Pre-EclampsiaPremature Birth

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesObstetric Labor, PrematureObstetric Labor Complications

Study Officials

  • Paul Leeson, PhD, FRCP

    University of Oxford Department of Cardiovascular Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 13, 2013

First Posted

June 28, 2013

Study Start

August 1, 2011

Primary Completion

September 1, 2017

Study Completion

September 1, 2017

Last Updated

May 25, 2016

Record last verified: 2016-05

Locations